Physician

David Elkayam, MD

According to 2025 Medicare claims, David Elkayam, MD (NPI: 1871589234) practices allergy/immunology in the Bellingham, WA market, with the plurality of this provider's patient population coming from Whatcom, WA. This provider's primary affiliated billing organization is BELLINGHAM ASTHMA ALLERGY IMMUNOLOGY CLINIC PS (NPI: 1174672281; TIN: 912083521) and primary practice location at 98225-1946. Elkayam is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Elkayam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 183 traditional Medicare patients, billed 43,765 HCPCS/CPT codes, and received $933,280 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 450 prescription claims across 129 beneficiaries totaling $178,390 in drug costs, led by Xolair (Omalizumab). DME data shows 153 claims. Open Payments data shows 237 records totaling $322,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $146,671 to $933,280. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $63,883 to $178,390. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,796 and ending at $2,727.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$467K$933K2015 Medicare payment: $146,671 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $178,557 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $217,035 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $196,049 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $281,354 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $331,034 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $390,309 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $570,028 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $802,787 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $933,280 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152286,877$146,671
20162238,521$178,557
201725410,039$217,035
20182378,003$196,049
2019230340,946$281,354
2020181644,518$331,034
2021141902,872$390,309
2022221177,917$570,028
202326437,428$802,787
202418343,765$933,280

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$117K$235K2015 Drug cost: $63,883 (USD; Tot_Drug_Cst)2016 Drug cost: $59,781 (USD; Tot_Drug_Cst)2017 Drug cost: $55,468 (USD; Tot_Drug_Cst)2018 Drug cost: $71,508 (USD; Tot_Drug_Cst)2019 Drug cost: $198,877 (USD; Tot_Drug_Cst)2020 Drug cost: $167,834 (USD; Tot_Drug_Cst)2021 Drug cost: $146,283 (USD; Tot_Drug_Cst)2022 Drug cost: $155,757 (USD; Tot_Drug_Cst)2023 Drug cost: $234,993 (USD; Tot_Drug_Cst)2024 Drug cost: $178,390 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201584440$63,883
201698448$59,781
201787405$55,468
2018107437$71,508
2019112509$198,877
2020104513$167,834
2021102509$146,283
2022120503$155,757
2023155593$234,993
2024129450$178,390

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$126K$251K2015 Medicare payment: $251,244 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $131,654 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $140,308 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $105,890 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $81,131 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $128,965 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $89,814 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $96,011 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $104,124 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $89,544 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R253$251,244
2016N/R166$131,654
201711207$140,308
2018N/R166$105,890
2019N/R142$81,131
2020N/R166$128,965
2021N/R178$89,814
2022N/R208$96,011
2023N/R232$104,124
2024N/R153$89,544

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3535$144
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3944$130
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3745$91
94375Test to measure rate of airflow4858$29
95012Test to measure the level of nitric oxide gas4962$15

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab18504$63,226
Breo ElliptaFluticasone/Vilanterol20960$12,404
DuleraMometasone/Formoterol14720$7,959
SymbicortBudesonide/Formoterol Fumarate21810$6,140
EpinephrineEpinephrine17224$5,886

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1551Injection, immune globulin (cutaquig), 100 mgNN/R13$57,717
J1555Injection, immune globulin (cuvitru), 100 mgNN/R14$28,617
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R37$1,981
J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mgNN/R12$536
Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 daysNN/R13$310

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$7,052Consortium of Independent Immunology Clinics, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.198$315,615GlaxoSmithKline, LLC.
Ownership / Investment InterestsReported value of ownership or investment interests.1$2,000Consortium of Independent Immunology Clinics, LLC

FAQ

What Medicare data is available for David Elkayam, MD?

Tedicare shows public-source Medicare data for David Elkayam, MD (NPI 1871589234), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Elkayam, MD have ACO affiliation data?

David Elkayam, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to David Elkayam, MD?

David Elkayam, MD is linked to BELLINGHAM ASTHMA ALLERGY IMMUNOLOGY CLINIC PS (billing NPI 1174672281) in the available physician profile data.

Does David Elkayam, MD have Open Payments data?

David Elkayam, MD has 237 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.